scholarly journals INTERLEUKIN-6 AND THE RISK OF ADVERSE OUTCOMES IN PATIENTS AFTER AN ACUTE CORONARY SYNDROME: OBSERVATIONS FROM THE SOLID-TIMI 52 TRIAL

2016 ◽  
Vol 67 (13) ◽  
pp. 442
Author(s):  
Christina Fanola ◽  
David Morrow ◽  
Christopher Cannon ◽  
Petr Jarolim ◽  
Mary Ann Lukas ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Interleukin 6 ◽  
Adverse Outcomes ◽  
Coronary Syndrome

The link between anemia and adverse outcomes in patients with acute coronary syndrome

2019 ◽  
Vol 17 (3) ◽  
pp. 151-159 ◽  
Author(s):  
Paul Guedeney ◽  
Sabato Sorrentino ◽  
Bimmer Claessen ◽  
Roxana Mehran
Keyword(s):  
Acute Coronary Syndrome ◽  
Adverse Outcomes ◽  
Coronary Syndrome

scholarly journals Impact of frailty on hospital adverse outcomes in elderly admitted with acute coronary syndrome

2020 ◽  
Vol 81 (1) ◽  
pp. 4
Author(s):  
Fernando Montenegro Sá ◽  
F�tima Saraiva ◽  
Francisco Soares ◽  
Jos� Leite ◽  
Jo�o Morais
Keyword(s):  
Acute Coronary Syndrome ◽  
Adverse Outcomes ◽  
Coronary Syndrome

scholarly journals Increased serum levels of interleukin-6 and von Willenbrand Factor in early phase of acute coronary syndrome in a young and multiethnic Malaysian population

Heart Asia ◽  
2012 ◽  
Vol 4 (1) ◽  
pp. 146-150 ◽  
Author(s):  
Wen Ni Tiong ◽  
Alan Yean Yip Fong ◽  
Edmund Ui Hang Sim ◽  
Hiang Chuan Chan ◽  
Tiong Kiam Ong ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Interleukin 6 ◽  
Early Phase ◽  
Serum Levels ◽  
Coronary Syndrome ◽  
Malaysian Population

Adverse outcomes following emergency department discharge of patients with possible acute coronary syndrome

2009 ◽  
Vol 21 (6) ◽  
pp. 455-464 ◽  
Author(s):  
Conrad Loten ◽  
Geoffrey Isbister ◽  
Melissa Jamcotchian ◽  
Carolyn Hullick ◽  
Patrick MacElduff ◽  
...  
Keyword(s):  
Emergency Department ◽  
Acute Coronary Syndrome ◽  
Adverse Outcomes ◽  
Coronary Syndrome ◽  
Emergency Department Discharge

scholarly journals Prognostic Significance of B Type Natriuretic Peptide in Acute Coronary Syndrome

2014 ◽  
Vol 13 (2) ◽  
pp. 78-88 ◽  
Author(s):  
Nasreen Chowdhury ◽  
Md. Aminul Haque Khan ◽  
Md Mozammel Hoque
Keyword(s):  
Heart Failure ◽  
Acute Coronary Syndrome ◽  
Risk Stratification ◽  
Natriuretic Peptide ◽  
Prognostic Significance ◽  
Left Ventricular ◽  
Adverse Outcomes ◽  
Risk Of Death ◽  
Coronary Syndrome ◽  
Early Risk

Acute Coronary syndrome (ACS) is the most common cause of admission to the coronary care unit with highest risk of death and adverse outcomes. ACS accounts for 60–70% of all admissions in the hospital. Patients with ACS encompass a heterogeneous group that varies widely regarding severity of the underlying coronary artery disease, prognosis and response to treatment. Patients with the highest risk of subsequent events usually have the largest benefit of an intensified pharmacological treatment and early mechanical intervention. The prognosis for low-risk patients, on the other hand, is often difficult to improve further and these patients usually benefit more from a conservative management with a lower risk of side effects. Therefore, risk stratification is essential and should be initiated early and updated continuously throughout the hospital stay. Early risk stratification is usually performed by the use of clinical background factors, clinical presentation, electrocardiography and biochemical markers of myocardial damage. Levels of natriuretic peptides have been shown to reflect cardiac performance. The aim of this study was to review elaborately on B type Natriuretic Peptide (BNP) and its prognostic value in patient with ACS. This review focuses on the emerging role of these peptides in the early risk stratification of ACS patients. Elevation of BNP levels in acute MI and UA is predictive of a greater risk of death, post infarction heart failure, or  reinfarction. Post infarction studies demonstrate that elevated plasma BNP levels are associated with larger infarct size, increased probability of ventricular remodeling, lower ejection fraction, higher risk of heart failure, and increased mortality. This cardiac marker is a potent predictor of mortality in patients with all forms ACS. BNP measurements serve as an index of severity of the ischemic injury, as well as the degree of impairment in left ventricular function.DOI: http://dx.doi.org/10.3329/cmoshmcj.v13i2.21079

scholarly journals Statin Reduces C-Reactive Protein and Interleukin-6 in Normocholesterolemic Patients with Acute Coronary Syndrome

2008 ◽  
Vol 44 (1) ◽  
pp. 13 ◽  
Author(s):  
Ok Young Park ◽  
Soo Hang Kim ◽  
Young Keun Ahn ◽  
Nam Sik Yun ◽  
Ju Han Kim ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Interleukin 6 ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Coronary Syndrome
Sign in / Sign up

Export Citation Format

Share Document